Miist Therapeutics

Miist Therapeutics

Breatheasy – Smoking Cessation that Works.

HQ location
San Francisco, United States
Employees
Enterprise value
$28—42m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
*

$7.0m

Seed
Total Funding000k
More about Miist Therapeutics
Made with AI
Edit

MIIST is a healthcare startup focused on combating tobacco addiction through innovative smoking cessation therapeutics. The company offers a pocket-sized device that provides instant craving relief, making it accessible for 24/7 use. MIIST also offers personalized quitting plans tailored to each patient, optimizing their chances of successfully quitting smoking. The company primarily serves individuals addicted to smoking, including both adults and children, within the United States. Operating in the healthcare market, MIIST addresses a significant public health issue that causes over 480,000 deaths annually in the U.S. and costs the economy over $380 billion per year. The business model revolves around selling its therapeutic devices and personalized plans directly to consumers, generating revenue through product sales and potentially subscription-based services for ongoing support.

Keywords: smoking cessation, craving relief, healthcare, therapeutic device, personalized plans, tobacco addiction, public health, 24/7 usability, U.S. market, economic impact.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads